ICGS 2018 September 6-8, 2018 · Ph. +39 055 50351 • [email protected] ... General...

International Congress on Glaucoma Surgery

ICGS 2018

September 6-8, 2018Palais des Congrès de Montréal

Montreal, Canada

P R O G R A M M E

WELCOME TO THE CONGRESS

December 8 -9 2018 | Geneva, Switzerland

ISGS MASTERCLASSSAVE THE DATE

International Society of Glaucoma Surgery

Advanced Surgical Wetlab Course

www.isgs.info

rd

3

ISGS Executive BoardPresident Tarek ShaarawyVice President Mark SherwoodSecretary General Tanuj DadaTreasurer Keith Barton

Michael CooteWilliam E. Sponsel

Paul Chew

The course includes hands-on training in:

• MIGS

• Tubes

• Trabeculectomy

• Non Penetrating Glaucoma Surgery

• Cilio-ablation Techniques

For further information please visit

www.isgs.info

COURSE VENUE

Centre Médical Universitaire CMURue Michel Servet, 1

CH 1211 Geneva 4 - Switzerland

Viale G. Matteotti, 7 • 50121 Florence • ItalyPh. +39 055 50351 • www.oic.it • [email protected]

OIC Srl is a MedTech Trusted Partner

ORGANIZING SECRETARIAT


Montreal, Canada

11

WELCOME TO THE CONGRESS

Dear Colleagues,

It is a great pleasure to welcome you to the 9th International Congress on Glaucoma Surgery (ICGS), held at the Palais des Congrès, Montréal – Canada on September 6-8, 2018.

Over the last 15 years, the ICGS has emerged as the key scientific meeting in the field of Glaucoma that held the highest scientific calibre and offers an opportunity for immediate skill transfer from some of the most gifted glaucoma surgeons across the globe. This unique scientific meeting generates great enthusiasm and is renowned for garnering widespread interest and enrolment.

The world of glaucoma surgery is evolving fast and thus requires keen cooperation and harmonization between research, device innovations, and technical refinements in the surgical management of patients. The prime focus of the ICGS is glaucoma lasers and surgery; however it endeavours to incorporate all aspects of glaucoma care, including epidemiology, diagnostics and medical therapy in order to be increasingly relevant to the glaucoma practitioner.

Montréal is a city of great charm, vivacity, and gaiety, as well as one of unquestioned modernity and it is renowned for its international flavour and inspiring diversity. The French-English bilingualism and its unique mix of European and North American culture adds dynamism to the city. The congress venue is the Palais des Congrès de Montréal (PCM), located in downtown Montreal, near the historic and cultural areas. The PCM is one of North America’s most renowned convention and exhibition centres with its accessible and innovative facilities thereby giving the delegates adequate opportunity to visit exhibition booths during programme breaks and in between sessions.

We offer you our warmest welcome and hope to make the 9th ICGS Congress in Canada a memorable experience for you.

Tarek Shaarawy Mark Sherwood Tanuj DadaISGS

PresidentISGS

Vice PresidentISGS

Secretary General


September 6-8, 2018Palais des Congrès de Montréal Montreal, Canada

2


2

HONORARY PRESIDENT

Graham E. TropeMB, BCh., PhD, FRCSC, FRCS (Ed), FRC Ophth, Dip. Ophthalmol (RCP&S London)

Professor Ophthalmology, University TorontoDirector Glaucoma Service, Toronto Western Hospital

Dr. Graham E. Trope is Professor of Ophthalmology at the University of Toronto and Senior Scientist at the University Heath Network. He has directed the Glaucoma Service at University Health Network since 1984. He is the past Chairman of Ophthalmology at the University of Toronto and past Ophthalmologist in Chief at University Health Network.

He has published over 200 scientific articles.

He has been involved in Glaucoma Research and Treatment for over 30 years and is the Founder and Scientific Director of Glaucoma Research Society of Canada.

He is the past Editor in Chief of the Canadian Journal of Ophthalmology. He is a winner of the Ontario College of Physicians and Surgeons Council Award for his contributions to patient care. He was awarded the Queen Elizabeth 11 Diamond Jubilee medal for his contribution to Ophthalmology in Canada. He has trained 51 glaucoma fellows from all parts of Canada and the world and is a past examiner for the Royal College of Physicians and Surgeons of Canada. He has published two books, one titled “Glaucoma, A patient’s guide to the disease” and the other titled “Glaucoma Surgery”.


Montreal, Canada

33

CONTENTS

Committees page 4

General Information page 5

Social Events page 9

Scientific Information page 10

Exhibiton Area and Stand Directory page 13

Acknowledgements page 14

Scientific Programme

- Timetable page 16

- Thursday, September 6, 2018 page 18

- Friday, September 7, 2018 page 21

- Saturday, September 8, 2018 page 25

- Video Loop page 30

- Posters page 32

Wetlab page 42

Educational Partner Symposia page 43

Chair and Author Index page 45


September 6-8 2018Palais des Congrès de Montréal Montreal, Canada

4

COMMITTEES

EXECUTIVE BOARD

Tarek Shaarawy – PresidentMark Sherwood – Vice PresidentTanuj Dada – Secretary General

Keith Barton - TreasurerPaul Chew

Michael CooteWilliam E. Sponsel

ICGS HONORARY PRESIDENT

Graham E. Trope

LOCAL ORGANISING COMMITTEE (LOC CHAIRS)

Ali HafezPaul Harasymowycz

PROGRAMME CHAIR FOR ICGS 2018

Michael Coote

SCIENTIFIC COMMITTEES

SCIENTIFIC COMMITTEE FOR ICGS 2018Tarek Shaarawy Michael Coote

COMMITTEE FOR EVALUATING POSTERS

Tarek Shaarawy Michael Coote


Montreal, Canada

5

GENERAL INFORMATION

CONGRESS VENUE Palais des Congrès de Montréal - LEVEL 5 - East side 201, Viger Street West, QC, H2Z 1X7, Montréal - CanadaTel.: +1 514 871-8122 - http://congresmtl.com/en/

Cloakroom2nd FLOOR

Access to the Congress Venuefrom Westin Hotel

GROUND FLOOR

Access to the Congress Venue201 Viger Street

Main Room Parallel Room

Slide Centre

Exhibition AreaCatering Area

Registration DeskPoster Area

Video

Wetlab

LEVEL 5

517c 517d

518ab

519a

521a

GROUND FLOOR

LEVEL 5



6

GENERAL INFORMATION

ORGANISING SECRETARIAT

OIC s.r.l. Viale Giacomo Matteotti, 7 - 50121 Florence (Italy)Tel.: +39 055 50351 - Fax: +39 055 [email protected]

OIC Srl is a MedTech Trusted Partner

REGISTRATION DESK The Organising Secretariat Desk will be open for registration and information according to the following time schedule:

Thursday, September 6 10.00 to 19.30 Friday, September 7 07.00 to 18.30 Saturday, September 8 07.30 to 18.00

CONGRESS REGISTRATION FEES

* Application for the residents/fellows fee should be certified by a letter from the head of the department to be up-loaded in the on-line platform directly (pdf format is required), stating that the applicant is an ophthalmology resident at the time of registration. The fee for Residents and Fellows does not include the Social Dinner on September 7.

** Accompanying person fee includes: Welcome Reception during the Opening Ceremony on September 6 and Social Dinner on September 7.

*** Mandatory previous registrations to the Congress (only few places available). Registrations will be accepted on the “first come first served” basis.

REGISTRATION FEES (tax included, if applicable) On site

Delegates € 650,00

Residents* and Fellows* € 300,00

Canadian Residents* and Fellows* € 225,00

Exhibitors € 240,00

Accompanying persons** € 220,00

Social Dinner on September 7 for Exhibitors, Residents and Fellows € 165,00

Wet Lab*** € 150,00

meetingspecialists


Montreal, Canada

7

GENERAL INFORMATION

REGISTRATION FEES INCLUDE• Access to the exhibition• Congress kit including certificate of attendance (not included in Exhibitors’ fees) and

name badge• Final programme• Abstract book (available only online on www.icgs2018.org)• Working lunches and coffee breaks• Opening Ceremony and Welcome Reception on September 6• Social Dinner on September 7 (not included in Exhibitors’ fees and in Residents’ and

Fellows’ fees)

Registration is mandatory for participation in the scientific sessions and for all oral, video and poster presenters.

PARALLEL COURSERegistration to the Parallel Course is free of charge for participants registered to the Congress. The pre-registration is not required and the attendance is possible while seats are available. Requests for participation will be accepted on the “first come first served” basis.

BADGESParticipants are kindly requested to wear the name badge when entering the congress venue and to access any offered services. The access to the above mentioned areas and services is not allowed without the badge.

Badge color coding is as follows:Gold ISGS Executive Committee MembersRed FacultyNo color DelegatesYellow ExhibitorsBlue Accompanying Persons

CERTIFICATE OF ATTENDANCEThe certificate of attendance will be included in the congress kit.

COFFEE AND TEA BREAKSDuring morning and afternoon breaks, delegates will have the chance to visit the Poster and Video Area as well as the Exhibition Area.



8

GENERAL INFORMATION

LUNCH BOXESOn September 6, 7 and 8 lunch boxes will be provided. Participants will find the tickets for the lunch boxes collection in their course kit. Tickets shall be handed to the caterer staff.

EXHIBITION An exhibition of the latest pharmaceutical products, electromedical devices and scientific publications is located in Room 517D. Opening hours will be corresponding to the congress activities as follows:

Thursday, September 6 11.00 to 19.30 Friday, September 7 07.00 to 18.30 Saturday, September 8 07.30 to 18.00

CLOAKROOMFor the first and last day of the congress a cloakroom located in the Viger Hall will be open for delegates bringing in their suitcases. The cost is $5/suitcase. Delegates are not allowed to bring their suitcases inside the Congress areas on Level 5.

ABOUT MONTREALMontréal is a beautiful city renowned for its international flavor and inspiring diversity. Located on an island in the St. Lawrence River, it is home to approximately 1.6 million residents and the largest bilingual workforce in Canada. It is the largest French-speaking city outside France and a perfect blend of European energy and North American efficiency. One of the world’s top convention cities and a certified destination for sustainable events, there’s something for everyone here. You’ll find a friendly population, world-famous gastronomy, and an atmosphere of celebration!Vibrant nightlife and eclectic cuisine. Cobblestone streets and a horse-drawn calèche. In Montréal, the old city blends seamlessly with a modern metropolis of glass and steel, and trendy boutiques sit side-by-side with quaint bistros and brasseries.Montréal offers a unique tour of the gastronomic pleasures of the world. With more than 4,000 restaurants, serving the national cuisine of some 80 countries, no wonder this city is considered one of the world’s leading culinary centers.You may enjoy the artisan studios of the Old Port, or the shops, theaters, and major department stores of the underground city. Montréal’s artistic scene includes one of the world’s leading orchestras, an internationally-renowned ballet company, English and French theaters, comedy clubs, and dozens of museums and galleries.For more details on Montréal and available tours, visit www.tourisme-montreal.org


Montreal, Canada

9

GENERAL INFORMATION

PUBLIC TRANSPORTATION IN MONTREALPublic transport is a great way to see the city. Hop on the metro and in just 10 minutes you’re at a museum, restaurant or in Old Montréal. Affordable and reliable, the metro can be accessed via the city’s Underground Pedestrian Network: two of the four main lines connect downtown to major tourism sites as well as to numerous bus stops and train stations. Weekly passes are available. Metro operating hours are Monday to Friday and Sunday from 5.30 to 1, and Saturday from 5.30 to 1.30. The average wait time between trains is eight minutes and three minutes during rush hour.

If you prefer getting around by taxi, it’s easy to flag one down on the street. You’ll also find them at one of the city’s many taxi stands or in front of most major hotels.

Taxi Diamond +1 514 273-6331 Taxi Coop +1 514-725-9885Taxi Champlain +1 514-271-1111

SOCIAL EVENTS

The following Social Events have been planned for congress participants.Tickets for the reserved events will be included in the personal congress kit delivered to participants upon registration.

Thursday, September 6 at 18.30CONGRESS RECEPTIONThe Congress Reception will take place at the Congress Venue in the Exhibition Area.

Friday, September 7 at 19.30SOCIAL DINNERThe Social Dinner will take place at The Windsor Ballrooms (1170, rue Peel, Bureau 110 Montréal, Quebec, H3B 4P2)Tel.: (514) 393-3588 On site registrations will be accepted according to availability.If you require further information or if you have food allergies or need special meals please contact the Registration Desk on site.



10

SCIENTIFIC INFORMATION

OFFICIAL LANGUAGEThe official language of the 9th International Congress on Glaucoma Surgery is English. All participants are encouraged to join discussions, independently of their fluency in English as the exchange of ideas and critical evaluation of presentations is the main purpose of the event.

MAIN SESSIONSAll plenary sessions will be held in Room 517 C (level 5).

POSTERSPosters shall be put up by authors in the appropriate numbered space in the Poster Area (Room 517D – level 5). They shall be put up on Thursday, September 6, starting from 10.00 and will remain until Saturday, September 8 when they have to be removed starting from 18.00. The poster discussion will take place during morning and afternoon tea breaks according to the final programme schedule. Attendance at least one break is mandatory.Authors are kindly requested to remain near their poster in order to answer to questions from their colleagues. Participants are also invited to visit the poster sessions during morning and afternoon coffee and tea breaks. Each author is kindly requested to respect the assigned position for his/her poster/s. The necessary material to put up the poster will be provided directly in the Poster Area.The Organising Secretariat is not responsible for those posters that are not removed at the end of the Congress.

VIDEO LOOPDelegates will have the opportunity to enjoy videos on innovative and educational topics regarding glaucoma surgery. Videos will be projected in loop in the Poster area (Room 517D – level 5) on 6, 7 and 8 September during the scientific sessions.Please see pages 30-31 for the list of videos that will be shown.

ABSTRACT BOOKICGS abstracts will be available to the participants on the Congress website www.icgs2018.org

SPONSORED SYMPOSIALunchtime and Breakfast Educational Partner Symposia will be held on September 6, 7 and 8 in Main Room 517C and will allow Sponsors to present their latest innovations, offering delegates the chance to exchange ideas with colleagues while acknowledged leaders in the field of Glaucoma Surgery discuss their specialist subject. These Symposia are not CME accredited. The schedule of Educational Partner Symposia can be found on page 43.


Montreal, Canada

11

SCIENTIFIC INFORMATION

SLIDE PREVIEW ROOMAll meeting rooms are equipped with a computer slide projector. It will be not possible to use personal laptops in the meeting rooms. Speakers are kindly requested to use “PowerPoint” (Windows or Macintosh/Apple) for their presentations. The dimensions of PowerPoint presentation should not exceed 300 MB, videos included. Please use “.gif” and “.jpg” extensions for images. Other types of extensions will be accepted, provided they can be recognized by PowerPoint. The use of pens or memory stick is advisable to download presentations, and should be handed to technicians at the Slide Preview Room well in advance. Please remember to collect your memory pen from the Slide Centre at the end of the session.

WI-FI INTERNET CONNECTIONFree Wi-Fi Internet connection will be available in all meeting rooms and common spaces.

CME DESIGNATIONSMOC Section 1: The 9th International Congress on Glaucoma Surgery is an Accredited Group Learning activity under (Section 1) as defined by the Maintenance of Certification (MOC) Program of the Royal College of Physician and Surgeons of Canada (RCPSC) and was approved by the Canadian Ophthalmological Society. Participants may claim a maximum of 17,5 hours (credits are automatically calculated). AMA PRA category 1: Through an agreement between the RCPSC and American Medical Association (AMA), physicians may convert Royal college MOC credits to AMA PRA category 1 credits. For more information on the process to convert visit: https://www.ama-assn.org/education/agreement-royal-college-physicians-surgeons-canada UEMS for ECMEC: Live educational activities recognized by the RCPSC as Accredited Group Learning Activities (Section 1) are deemed by the European Union of Medical Specialists (UEMS) eligible for ECMEC®. Further information about credits will be given at the Registration Desk on site.LEARNING OBJECTIVES: By participating in ICGS 2018, attendees will be able to:• Identify the theoretical and practical capabilities necessary for glaucoma surgery• Demonstrate new skills garnered from skills transfer and debate with other

practitioners • Discuss clinical experiences relevant to glaucoma surgery• Contribute to the overall capacity of glaucoma surgery in the world



12

SCIENTIFIC INFORMATIONSessions Learning Objectives

Thursday, September 6

12.30 Honorary President Keynote Lecture - Glaucoma Surgery Developing Through My Eyes

To recount the history of glaucoma education and its future directions.

14.30 What Works - free papers 1 To demonstrate their capacity in existing glaucoma surgical techniques.

15.30 Better Basics - free papers 2

17.00 The Globe: Glaucoma Surgery Around the World To assess the reach and breadth of glaucoma surgical training around the world.To describe training opportunities and models in less developed health systems.

18.00 Clive Migdal Lecture To consider the interaction and support that health care systems can provide each other.

Friday, September 7

09.00 How One - free papers 3 To reflect upon methodologic issues in glaucoma surgery. To reflect upon method and the effect on outcome in Glaucoma Surgery.10.00 How Two - free papers 4

09.00 Parallel Course 1 Blebs: the Big, Bad And Beautiful. Managing the Miscreants

To describe classification, discernment and interventional techniques in filtration surgery and the outcomes.

10.00 Parallel Course 2 Rescuing Glaucoma Surgery - Tips And Techniques

11.30 Thom J. Zimmerman Lecture To reflect upon the process of acquiring, disseminating and evaluating information about glaucoma surgery.

12.00 Executive ReVision. References reviewed To engage in and evaluate the significant glaucoma surgical studies in a discursive style.

14.30 Clinical Problems Worth Solving Glaucoma Problem Solving (GPS 1)

To review clinical issues for which there is incomplete evidence.

15.30 Parallel Course 3 - Resident Course: Gonioscopy, Optic Nerve Evaluation And Perimetry

To review techniques related to gonioscopy, optic nerve evaluation and perimetry.

16.45 Montreal Grand Round To assess the development of clinical scenarios and decision making.

Saturday, September 8

08.15 Why and When One - free papers 5 To reflect on the indications and context of glaucoma surgery. To consider various options related to surgical decision making.09.00 Why and When Two - free papers 6

11.00 Doug Johnson Lecture To describe the significant changes that have occurred in glaucoma surgery in the last decade.

11.30 Interrogation and Reward - Video and Poster Prize Session

To determine the effectiveness of communication of surgical issue in video and poster format

14.00 Inflammatory Plumbing - Glaucoma Surgery in Uveitis To identify surgical pearls for glaucoma surgery in uveitis. To identify tips and tricks for glaucoma surgery and cataract14.45 Windows and Water - Glaucoma Surgery and Cataract

15.30 Managing Missing Aqueous - Glaucoma Surgery and Aqueous Misdirection

To manage missing aqueous in glaucoma surgery

16.30 “Seeing to the End” - Glaucoma Problem Solving (Gps2)

To describe problem solving techniques for trauma, hypotony and glaucoma surgery in Low Tension Glaucoma.


Montreal, Canada

13

EXHIBITION AREA AND STAND DIRECTORY

Main RoomParallel Room

Slide Centre

Exhibition AreaCatering Area

Registration DeskPoster Area

VideoWetlab Room

517d 517c

518ab

519ab

521a

Video Loop Area

Catering Area

Poster Area

RegistrationRelaxArea

NewReg.

19

18

17

16

15

4 3

9

8

6

2



LEVEL 5EXHIBITION AREA AND STAND DIRECTORY

DIRECTORYALCON 2 JAYPEE BROTHERS 17

ALLERGAN 4 LABORATOIRES THEA 8

CANADIAN GLAUCOMA SOCIETY 16 NEW WORLD MEDICAL 15

ELLEX 9 RHEON MEDICAL 18

GLAUKOS 6 SANTEN PHARMACEUTICAL 3

I-MED PHARMA 19

www.icgs2018.orgWIFI NETWORK:

icgs2018PASSWORD:ICGS2018



14

ACKNOWLEDGEMENTSThe International Society of Glaucoma Surgery wishes to express its gratitude to all

Sponsors for their generous support to the Congress.

PLATINUM SUPPORTERS

BRONZE SUPPORTER

EXHIBITORS


Montreal, Canada

15SCIENTIFIC PROGRAMME



16

Thursday, September 6, 2018Main Room

12.00-13.00 Opening and Welcome

12.30-13.00 Honorary President Keynote Lecture

13.00-14.30 Educational Partner Lunch Symposium

14.30-15.30 What Works - free papers 1

15.30-16.30 Better Basics - free papers 2

16.30-17.00 Afternoon Tea with Posters and Videos (Exhibition Area)

17.00-18.00 The Globe: Glaucoma Surgery around the World

18.00-18.30 Clive Migdal Lecture

18.30-19.30 Congress Reception (Exhibition Area)

Friday, September 7, 2018Main Room Parallel Room

08.00-09.00 Educational Partner Breakfast Symposium

09.00-10.00 How One - free papers 3Parallel Course 1 - Blebs: The Big, Bad and Beautiful. Managing the

Miscreants

10.00-11.00 How Two - free papers 4 Parallel Course 2 - Rescuing Glaucoma Surgery - Tips and Techniques

11.00-11.30 Morning Tea with Posters and Videos (Exhibition Area)

11.30-12.00 Thom J. Zimmerman Lecture

12.00-13.00 Executive ReVision. References Reviewed


14.30-16.30 Clinical Problems Worth SolvingGlaucoma Problem Solving (GPS 1)

15.30-16.30Parallel Course 3 - Resident Course: Gonioscopy, Optic Nerve Evaluation

and Perimetry


16.45-17.30 Montreal Grand Round Circus

TIMETABLE TIMETABLE


Montreal, Canada

17

Saturday, September 8, 2018Main Room Wetlab Room

08.15-09.30 Why and When One - free papers 5 08.30-10.30

09.30-10.30 Why and When Two - free papers 6 Wetlab

10.30-11.00 Morning Tea with Posters and Videos (Exhibition Area)

11.00-11.30 Doug Johnson Lecture

11.30-12.30 Interrogation and RewardVideo and Poster Prize Session


14.00-14.45 Inflammatory Plumbing - Glaucoma Surgery in Uveitis

14.45-15.30 Windows and Water - Glaucoma Surgery and Cataract

15.30-16.00Managing Missing Aqueous -

Glaucoma Surgery and Aqueous Misdirection


16.30-18.00 “Seeing to the End”Glaucoma Problem Solving (GPS 2)

18.00 Goodbye from Montreal - Closing

TIMETABLE



18

THURSDAY, SEPTEMBER 6, 2018

12.00 OPENING AND WELCOME Main Room

12.00 Welcome to Montreal and to the ICGS 2018 Tarek Shaarawy (Switzerland) and Catherine Birt (Canada)

Michael Coote (Australia) - Scientific Programme Ali Hafez (Canada) - Local Committee

12.30 Honorary President Keynote Lecture KL1 Introduction: Catherine Birt (Canada) Graham E. Trope (Canada) A guide to surviving a glaucoma surgical career

13.00 EDUCATIONAL PARTNER LUNCH SYMPOSIUM Main Room14.30 (see page 43)

14.30 WHAT WORKS - free papers 1 Main Room15.30 Chairs: Colin Clement (Australia), Tanuj Dada (India), Mark Lesk (Canada)

14.30 Invited Lecture IL1 Patient oriented outcomes: Preliminary PROMS Tarek Shaarawy (Switzerland)

14.40 Twenty-year outcomes in newly diagnosed glaucoma patients: mortality, visual FP1.1 function and surgical outcomes G. Ratnarajan, C. King, J. Sherwin, J. Salmon (United Kingdom)

14.48 The effect of trabeculectomy surgery on the central visual field in patientsFP1.2 with glaucoma using microperimetry and optical coherence tomography H. Chan, G. Ratnarajan, J. Jolly, I. Yusuf, J. Salmon (United Kingdom)

14.56 Outcome of Ahmed glaucoma valve surgery as primary treatmentFP1.3 A. Basia (India)



Montreal, Canada

19


15.04 Evaluation of the early to mid-term efficacy and safety of deep sclerectomy FP1.4 for open-angle glaucoma in an Australian population C. Clements, M. Hui (Australia)

15.12 Nonpenetrating deep sclerectomy with mitomycin C: 5 year follow-up with FP1.5 analysis of IOP control and visual field survival G. Slagle, W. Sponsel, S. Groth (USA)

15.20 Discussion

15.30 BETTER BASICS - free papers 2 Main Room16.30 Chairs: Sebastien Gagne (Canada), Cindy Hutnik (Canada), Nader Bayoumi (Egypt)

15.30 Invited LectureIL2 Innovative methods to modulate wound healing Cindy Hutnik (Canada)

15.42 Trabeculectomy: comparison of long term efficacy of injection or sponge FP2.1 application of mitomycine-C M. Carrière, C. Lajoie, E. Chalifoux (Canada)

15.50 Efficacy and safety of subconjunctival injection of low-dose mitomycin-C FP2.2 compared tointraoperative application in deep sclerectomy P. Alaghband, N. Anand (United Kingdom)

15.58 “Smart trab” - 2.5 years results of modified trabeculectomy. Success rate andFP2.3 complications C. Terzidou, A. Trivli, G. Dalianis (Greece)

16.06 Impact of phacoemulsification on filtering bleb morphology identified via three-FP2.4 dimensional anterior segment optical coherence tomography A. Narita, T. Miyake, K. Sugihara, T. Ishikawa, J. Seguchi (Japan)

16.14 Invited Lecture IL3 New methods of Trabeculectomy Tanuj Dada (India)

16.26 Discussion

16.30 Afternoon tea with posters and videos Exhibition Area




20


17.00 THE GLOBE: GLAUCOMA SURGERY AROUND THE Main Room18.00 WORLD Chairs: William Eric Sponsel (USA), André Mermoud (Switzerland),

17.00 Surgical developments for the developing worldMS1.1 André Mermoud (Switzerland)

17.06 Plumbing where it countsMS1.2 Leon Herndon (USA)

17.12 Technical challenges in glaucoma care deliverMS1.3 Anthony Realini (USA)

17.18 Tubes as primary surgeryMS1.4 Kin Sheng Lim (United Kingdom)

17.24 Developing teaching programs for AfricaMS1.5 Karim Damji (Canada)

17.30 Glaucoma surgery in the Australian outbackMS1.6 Ashish Agar (Australia)

17.36 Screening in South Africa MS1.7 Stephen Cook (South Africa)

17.42 Discussion

18.00 CLIVE MIGDAL LECTURE Main Room18.30 Introduction: Tarek ShaarawyL1 William Eric Sponsel (USA) - “Plumbing and Wiring, Water and Light”

18.30 Congress Reception Exhibition Area19.30

FRIDAY, SEPTEMBER 7, 2018THE HOW: TECHNIQUE DAY


Montreal, Canada

21

THURSDAY, SEPTEMBER 6, 2018 FRIDAY, SEPTEMBER 7, 2018THE HOW: TECHNIQUE DAY

08.00 EDUCATIONAL PARTNER BREAKFAST SYMPOSIUM Main Room09.00 (see page 43)

09.00 HOW ONE - free papers 3 Main Room10.00 Chairs: Catherine Birt (Canada), Robert David Fechtner (USA)

09.00 Short-term surgical outcome of modified gonio-assisted transluminal FP3.1 trabeculotomy with double-mirror goniolens for primary angle closure glaucoma K. Mori, Y. Yamamoto, K. Imai, Y. Ikeda, M. Ueno, C. Sotozono,

S. Kinoshita (Japan)

09.06 Evaluation of safety and efficacy of implantation of a collagen implant in the FP3.2 supraciliary space in decreasing intraocular pressure in patients having

coexisting pathologies - Preliminary results V. Kumar, A. Shradqa, G. Dushina, M. Frolov, A. Bezzabotnov (Russia)

09.12 Safety and effectiveness of implantation of a stainless steel implant in the FP3.3 supraciliary space in decreasing intraocular pressure in glaucoma patients A. Shradqa, V. Kumar, G. Dushina, A. Bezzabotnov, M. Frolov (Russia)

09.18 Combined XEN-Baerveldt implantation for refractory childhood glaucoma FP3.4 F. Grehn, E. Hoffmann, T. Arad (Germany)

09.24 Pathogenetically directed treatment method of ciliochoroidal detachmentFP3.5 after glaucoma surgery T. Sokolovskaya, Y. Kovalenko, Y. Gorodetskaya (Russia)

09.30 Is a day 1 postoperative review required following ab interno Xen gel stent FP3.6 surgery? Southern UK Xen Audit Group, A. Karimi, D. Lindfield (United Kingdom)

09.36 Safety and efficacy of ab-externo Schlemm’s canal dilation using Kumar’s 3rd FP3.7 generation metallic Schlemm’s canal expander in management of glaucoma in cataract patients G. Dushina, V. Kumar, A. Bezzabotnov, A. Shradqa, M. Frolov (Russia)

09.42 Discussion



22


09.00 PARALLEL COURSE 1 Parallel Room10.00 BLEBS: THE BIG, BAD AND BEAUTIFUL. MANAGING THE MISCREANTS Course Leaders: Michael Coote (Australia), Mark Lesk (Canada),

Shamira Perera (Singapore), Tarek Shaarawy (Switzerland), Mark Sherwood (USA)

10.00 HOW TWO - free papers 4 Main Room11.00 Chairs: Keith Barton (United Kingdom), Garfield Miller (Canada), Zeynep Aktas (Turkey)

10.00 eyePlate, a newly designed implant combined with the adjustable eyeWatch FP4.1 device A. Villamarin1, S. Roy1, C. Stergiopulos1, N. Stergiopulos1, C. Kniestedt1, F. Topouzis2, E. Detorakis2, A. Mermoud1 (1Switzerland, 2Greece)

10.06 CO2 laser assisted deep sclerectomy (CLASS)FP4.2 A. Aref1, S. Roy2, A. Mermoud2, T. Shaarawy2 (1Egypt, 2Switzerland)

10.12 New technique for avoid glaucoma and other complications after FP4.3 vitreoretinal surgery with silicon oil (Masoud Nano balloon) M. Masoudnaseri (Ukraine)

10.18 Pars plana EX-PRESS Shunt for management of persistent glaucoma after FP4.4 Silicone oil removal in vitrectomized eye. A potential novel technique A. Abdullatif, H. El Saied (Egypt)

10.24 Goniotomy with trabecular meshwork excision using the Kahook dual blade FP4.5 in severe and refractory glaucoma: six month outcomes K. Mansouri1, L. Salinas1, L. Seibold2, S. Dorairaj2 (1Switzerland, 2USA)

10.30 Is the timing of laser goniopuncture after deep sclerecotomy important?FP4.6 D. Holmes, M. Hui, C. Clement (Australia)

10.36 Trascleral cyclophotocoagulation diode laser: our experience in improving safety FP4.7 and efficacy S.M. Ezzouhairi (Morocco)

10.42 Comparison of surgical outcomes between ab-interno trabeculectomy usingFP4.8 a Kahook Dual Blade and iStent trabecular micro-bypass stent D. Lee, J. King, S. Thomsen, J. An (USA)

10.48 Discussion


September 6,-8 2018Palais des Congrès de Montréal

Montreal, Canada

23


10.00 PARALLEL COURSE 2 Parallel Room11.00 RESCUING GLAUCOMA SURGERY - TIPS AND TECHNIQUES Course Leaders: Robert David Fechtner (USA),

Ayesha Karimi (United Kingdom), Marcelo Nicolela (Canada), Chelvin Sng (Singapore)

11.00 Morning tea with posters and videos Exhibition Area

11.30 THOM J. ZIMMERMAN LECTURE Main Room12.00 Introduction: Mark Sherwood (USA)L2 Jeffrey M. Liebmann (USA) - “Advancing and Transmitting Surgical Knowledge”

12.00 EXECUTIVE ReVISION. REFERENCES REVIEWED Main Room13.00 Introduction: Tarek Shaarawy (Switzerland) Chairs: Leon Herndon (USA), Jeffrey M. Liebmann (USA),

Susan Wakil (USA)





24


14.30 CLINICAL PROBLEMS WORTH SOLVING Main Room16.30 GLAUCOMA PROBLEM SOLVING (GPS 1)

14.30 Falling IOLs and rising IOPs. PXF.MS3.1 Chair: Paul Harasymowycz (Canada) Panelists: Sebastian Gagne (Canada), Nathan Kerr (Australia),

Arvind Neelakantan (USA), Gokulan Ratnarajan (United Kingdom), Steven Schendel (Canada)

15.15 ICE flows. ChallengesMS3.2 Chair: Leon Au (United Kingdom) Panelists: Catherine Birt (Canada), Franz Grehn (Germany),

Loon Seng Chee (Singapore), Chelvin Sng (Singapore), Andrew Walkden (United Kingdom)

15.50 Big Problems in Small Eyes. Nanophthalmos MS3.3 Chair: Kaweh Mansouri (Switzerland) Panelists: Abdullatif Abdussalam (Egypt), Michael Coote (Australia),

Yoshiaki Kiuchi (Japan), Mohammad Pakravan (Iran), Shamira Perera (Singapore)

15.30 PARALLEL COURSE 3 Parallel Room16.30 RESIDENT COURSE: GONIOSCOPY AND OPTIC NERVE EVALUATION Course Leaders: Tanuj Dada (India), Ali Hafez (Canada),

Nathan Kerr (Australia)


16.45 MONTREAL GRAND ROUND CIRCUS Main Room17.30 Chairs: Paul Harasymowycz (Canada), Hadi Saheb (Montreal Canada) Panelists: Catherine Birt (Canada), Robert David Fechtner (USA),

Alaa Mofti (Canada), Roland Seif (Canada), Tarek Shaarawy (Switzerland), Mark Sherwood (USA)

SATURDAY, SEPTEMBER 8, 2018THE WHY AND WHEN: CLINICAL APPLICATIONS DAY

September 6,-8 2018Palais des Congrès de Montréal

Montreal, Canada

25



08.15 WHY AND WHEN ONE - free papers 5 Main Room09.30 Chairs: Leon Au (United Kingdom), Sebastian Gagne (Canada), Sidi Mohammed Ezzouhairi (Morocco), Yasmine El Sayed (Egypt)

08.15 Phaco-endocycloplasty vs phaco-trabeculectomy in PACG: 1-year results of a FP5.1 pilot study V. Pathak Ray, S. Badakare, V. Puri, D. Rao, N. Choudhari (India)

08.21 Tube shunt revision with excision of fibrotic capsule, with MMC and a FP5.2 collagen matrix implant: a 3-year follow-up study A. Salimi, P. Harasymowycz (Canada) 08.27 Efficacy and safety of ABiC in primary open angle glaucoma (POAG) over a FP5.3 24-month period M. Khaimi (USA)

08.33 Outcomes of Ahmed valve implants in childhood glaucoma at a tertiary FP5.4 eyecare center in the Middle East A. Mofti1, A. Al-Harbi1, M. Alsuhaibani1, A. Aljaber1, L. Altamimi1, I. Al-Jadaan1, S. Ahmad2, R. Malik1 (1Saudi Arabia, 2USA)

08.39 The surgical outcome of glaucoma drainage device implants in pediatricFP5.5 glaucoma; a fourteen-year experience M. Bagheri, K. Mireskandari, A. Ali, N. Najm-Tehrani (Canada)

08.45 Goniotomy with trabecular meshwork excision versus trabecular bypass FP5.6 device implantation in glaucoma patients undergoing cataract extraction: 12-month results S.K. Dorairaj, M.Y. Kahook, B.K. Williamson, L.K. Seibold, M.K. ElMallah, I.P. Singh (USA)

08.51 Xen-45 implant as treatment for uveitic hypertensive crisesFP5.7 A. Qureshi, L. Au, N. Jones (United Kingdom)

08.57 Efficacy and safety of ab-interno Xen gel stent following failed trabeculectomyFP5.8 K. Martin, A. Karimi, M. Hopes, D. Lindfield (United Kingdom)

09.03 Prospective evaluation of XEN gel implant in eyes with pseudoexfoliative glaucomaFP5.9 K. Mansouri, J. Guidotti, A. Mermoud (Switzerland)

09.09 The long-term outcomes of endocyclophotocoagulation (ECP) in moderate FP5.10 and advanced glaucoma A. Mohite, S. Lee, S. Murthy, S. Ramanathan, P. Corridan (United Kingdom)

09.15 Discussion



26



08.30 WETLAB Wetlab Room10.30 (see page 42)

09.30 WHY AND WHEN TWO - free papers 6 Main Room10.30 Chairs: Franz Grehn (Germany), Hady Saheb (Canada),

Antonio Maria Fea (Italy), Gokulan Ratnarajan (United Kingdom)

09.30 The SPECTRUM Registry: 12 and 24 month results from a global real worldFP6.1 study of 2400 glaucoma eyes treated with micro invasive glaucoma surgery using the Hydrus® Microstent A. M. Fea, L. Dallorto, C. Lavia (Italy)

09.36 Standalone MIGS: 3 year data from the Sydney Multicentre Hydrus studyFP6.2 A. Agar, C. Clement, A. White, R. Lim (Australia)

09.42 Prospective randomized controlled pivotal study of second-generation FP6.3 trabecular micro-bypass stents implanted in conjunction with cataract surgery D. Lubeck (USA)

09.48 Multi-center, multi-surgeon, real-world experience with second-generation FP6.4 trabecular micro-bypass stents in patients with glaucoma C. Clement, D. Manning, F. Howes, M. Shiu (Australia)

09.54 5-year outcomes of a prospective study of two trabecular micro-bypass FP6.5 stents compared to prostaglandin in newly diagnosed open-angle glaucoma A. Khouri (USA)

10.00 MIGS with 2nd generation trabecular micro-bypass stents in OAG eyes onFP6.6 one preoperative medication: 42-month outcomes S. Gagné (Canada)

10.06 A UK cost analysis of trabecular micro-bypass stents in patients with primary FP6.7 open-angle glaucoma from an NHS commission perspective K. Barton1, T. Jones1, H. Falvey2, M. Cantu1, L. Au1 (1United Kingdom, 2USA)

10.12 FP8 Ahmed valves in patients older than 85FP6.8 P. Crichton, A. Crichton, E. Sanders (Canada)

10.18 Discussion


Montreal, Canada

27



10.30 Morning tea with posters and videos Exhibition Area

11.00 DOUG JOHNSON LECTURE Main Room11.30 Introduction: Michael Coote (Australia) L3 Iqbal Ike Ahmed (Canada) - “The Journey Matters”

11.30 THE BEATEN EYE. TRAUMA12.30 Chair: Andrew Crichton (Canada) Panelists: Karim Damji (Canada), Michael Dorey (Canada),

Ziad Khoueir (Lebanon), Albert Khouri (USA), Mark Lesk (Canada)


14.00 INFLAMMATORY PLUMBING - Main Room14.45 GLAUCOMA SURGERY IN UVEITIS Chairs: Keith Barton (United Kingdom), Karin Oliver (Canada)

14.00 MIGS and uveitis - Can we make them work?MS6.1 Keith Barton (United Kingdom)

14.10 Uveitis is not all the same - Do we have any rules of the road?MS6.2 Karin Oliver (Canada)

14.20 GDDs and uveitis - The old warhorse!MS6.3 Leon Herndon (USA)

14.30 Filtration surgery and uveitis - What are the tricks and tips for maximising MS6.4 the chance of success? Hady Saheb (Canada)

14.40 Discussion



28



14.45 WINDOWS AND WATER - Main Room15.30 GLAUCOMA SURGERY AND CATARACT Chairs: Michael Coote (Australia), Paul Harasymowycz (Canada),

Wisam Ahmad Shihadeh (Jordan)

14.45 What are the options? Are MIGS worth their cost?MS7.1 Sylvia Groth (USA) 14.54 Cataract and tubes, trabs and other filters. How to keep the flow MS7.2 Paul Harasymowycz (Canada)

15.03 Future indications for combined glaucoma surgery - the view of a glaucoma specialist and a cataract surgeon

MS7.3 Frances Meier-Gibbons (Switzerland)

15.12 Cataract surgery and revision of blebs MS7.4 Michael Coote (Australia)

15.21 Discussion

15.30 MANAGING MISSING AQUEOUS - Main Room16.00 GLAUCOMA SURGERY AND AQUEOUS MISDIRECTION Chairs: Iqbal Ike Ahmed (Canada), Ali Hafez (Canada),

Ingeborg Stalmans (Belgium)

15.30 Why is it missed and what works, and what does not.MS8.1 Ingeborg Stalmans (Belgium)

15.37 When is it Aqueous Misdirection and when is it Angle Closure? MS8.2 Ali Hafez (Canada)

15.44 Methods of managingMS8.3 Iqbal Ike Ahmed (Canada)

15.51 Discussion



Montreal, Canada

29



16.30 “SEEING TO THE END” - Main Room18.00 GLAUCOMA PROBLEM SOLVING (GPS2)

16.30 The pressure is off. HypotonyMS9.1 Chair: Nathan Kerr (Australia) Panelists: Sylvia Groth (USA), Garfield Miller (Canada),

Sharma Reetika (India), Vanita Pathak Ray (India), Jing Wang (Canada)

17.00 How low is low? LTGMS9.2 Chair: Toby Chan (Canada) Panelists: Toby Chan (Canada), Colin Clement (Australia),

Mark Sherwood (USA), Lineu Shiroma (Brazil)

18.00 Goodbye from Montreal - Closing - Tarek Shaarawy (Switzerland)



30

VIDEO LOOP VIDEO LOOP

V01 Challenges and their management during pediatric Schlemm’s canal surgery Z. Aktas (Turkey)

V02 Hypertrophic dysaesthetic bleb following ab-interno Xen gel stent glaucoma surgery: management and ‘Switch and Stitch’ revision surgery D. Lindfield, A. Karimi (United Kingdom)

V03 Rescue operations after glaucoma filtering surgery A. Desai, J. Shakrawal, A. Behera, T. Sidhu, T. Dada (India)

V04 OMNI - A new surgical technique for glaucoma treatment I.A. Placinta1, J. Vila Arteaga1, C. Martínez Rubio1, P. Martínez López-Corell1, R. Molina Pallete1, I. Kane2 (1Spain, 2USA)

V05 Bent ab interno needle goniectomy A. Sheybani (USA)

V06 Gonioscopy assisted transluminal trabeculotomy in a case with juvenile glaucoma with scleral thinning Z. Aktas, O. Ocakoglu (Turkey)

V07 What to do when the suture stops during prolene GATT (gonioscopy assisted transluminal trabeculotomy) Z. Aktas (Turkey)

V08 Innovations in trabeculectomy M. Gagrani, T. Sidhu, J. Shakrawal, A. Behera, T. Dada (India)

V09 End stage / advanced glaucoma with failed surgery: a short case series of our approach L. Tejwani, R. Sharma (India)

V10 Intravitreal gas injection with Ahmed’s valve implantation in prevention of suprachoroidal haemorrhage in aphakic aniridic vitrectomized glaucomatous eyes: a pilot study H. El-Saied, A. Abdullatif (Egypt)

V11 Novel use of materials in cost-effective dry lab model construction for ophthalmic surgery Y.-H. Tham, M. Parnell, M. Abubakra, J. McHugh, G. Lascaratos, S. Jones, E. Hollick, D. McHugh, A. Kulkarni (United Kingdom)


Montreal, Canada

31

VIDEO LOOP VIDEO LOOP

V12 Irido-Zonulo-Hyaloido-Vitrectomy decoded V. Pathak Ray, I. Gulati, D. Rao, V. Malhotra (India)

V13 Bilateral total iris atrophy and refractory glaucoma following cosmetic artificial iris implants W. Shihadeh, M. Bilal (Jordan)



32

POSTERS POSTERS

ANGLE CLOSURE GLAUCOMA

P01 Angle closure from angle recession in an elderly male: a case report M.R. Macapagal, D.P. Chao-Po, A.M. Macasaet (Philippines)

CATARACT AND GLAUCOMA SURGERY

P02 Evaluation of the efficacy and safety of combined phacotrabeculectomy surgery in non-controlled primary open-angle glaucoma associated with cataract A. Asma, M.T. Nouri (Algeria)

P03 Outcomes after combined phacoemulsification and YAG-laser activation of trabecula (YAG-LAT) in controlled open-angle glaucoma T. Sokolovskaya, D. Magaramov, V. Teplovodskaya, V. Yashina (Russia)

P04 Malignant glaucoma during femtosecond laser assisted cataract surgery J.-C. Cheng, M.-H. Chiang, C.-L. Wu (Taiwan)

P05 Long-term safety and effectiveness of one, two, or three trabecular micro-bypass stents as treatment for OAG: 54 month outcomes A. Sheybani (USA)

P06 Long-term comparison of postoperative refractive outcomes between phacotrabeculectomy and phacoemulsification J.K. Chung, K.B. Lee (Korea)

P07 Corneal endothelial cell loss after phacoemulsification in eyes with prior acute angle-closure attack M. Seong (Korea)

P08 Intermediate results of a new twin site phaco-trabeculectomy D. Rao, V. Puri, V. Pathak Ray (India)

P09 Comparison of visual field progression before and after Ahmed glaucoma valve (AGV) and trabeculectomy with Mitomycin C (MMC) surgery in Asian eyes with glaucoma Y. Lim, V. Koh, W.H. Ton, E. Neo (Singapore)


Montreal, Canada

33

POSTERS POSTERS

P10 Outcome of phacotrabeculectomy with double placement of collagen matrix implant and MMC-0.04% with/without antiVEGF R. Sharma, L. Tejwani (India)

P11 Long term outcomes of the iStent trabecular microbypass in combination with phacoemulsification Y. Patodia, V. Kansal, J. Yohannan, D.K. Varma, D.Y. Tam, I.I.K. Ahmed (Canada)

P12 Excimer laser trabeculostomy (ELT), a MIGS procedure using no implants, lowers intraocular pressure over 8 years, both alone and with phaco M. Berlin1, M. Farajzadeh1, M. Toeteberg2, V. Roka3, L. Kleineberg3, R. Stodtmeister3, U. Giers3 (1USA, 2Switzerland, 3Germany)

CONGENITAL / PEDIATRIC GLAUCOMA

P13 Glaucoma in children with facial port wine stain N. Bayoumi, E. Elsayed (Egypt)

EPIDEMIOLOGY

P14 Changing the structure of clinical and epidemiological characteristics of primary open-angle glaucoma over 10 years in patients coming to surgical treatment E. Krinitsyna, V. Sergeeva, V. Gorodnichy, A. Kuroyedov (Russia)

P15 Comparison of treatment regimens for patients with primary open-angle glaucoma with the characteristics of disease progression. Part 1. Status of parameters of the IOP-levels R. Avdeev1, A. Aleksandrov1, N. Bakunina1, D. Belaya1, A. Brezhnev1, N. Volkova1, L. Gabdrakhmanov1, A. Galimova1, V. Gar’kavenko1, A. Getmanova1, V. Gorodnichiy1, A. Gusarevich1, D. Dorofeev1, Y. Dyukareva1, P. Zavadskiy2, A. Zakhidov3, O. Zvereva1, U. Karimov3, I. Kondrakova1, A. Kuroyedov1, S. Lanin1, D. Lovpache1, E. Molchanova1, Z. Nagornova1, O. Onufriychuk1, S. Petrov1, Y. Rozhko2, Z. Sangilbayeva4, A. Seleznev1, L. Tashtitova1, S. Usmanov1, A. Khohlova1, A. Shahalova1, R. Sevciuc5 (1Russia, 2Belarus, 3Uzbekistan, 4Kazakhstan, 5Moldova)

P16 Do eyes with esotropia have a high prevalence of narrow angles O. Kasner, A. Alali, R. Superstein (Canada)



34

POSTERS POSTERS

P17 Uniqueness of change analysis printout for predicting glaucoma severity T. Chakravarti (India)

GLAUCOMA MEDICATIONS

P18 The effect of prostaglandin analogues on central corneal thickness U.D. Uzunel (Turkey)

P19 Results of the study of neuronal markers in retinoprotection of primary open-angle glaucoma A. Gabdrakhmanova, S. Kurbanov, G. Abizgildina (Russia)

P20 Quantitative evaluation of uveoscleral outflow for optimisation of glaucoma treatment G. Stolyarov, H. Hayrapetyan, O. Lebedev (Russia)

P21 Meibomian gland dysfunction in patients treated with topical prostaglandin analogues J.Y. Ha, M.S. Sung, S.W. Park (Korea)

P22 Glaucoma severity, socioeconomic factors affecting glaucoma cost in India T. Chakravarti (India)

P23 Interim results of a prospective, randomized phase II study evaluating the safety and efficacy of novel sustained-release Travoprost intraocular implants L.J. Katz (USA)

P24 Experience of the combined treatment of an atrophy of the optic nerve by glaucomatous G. Abizgildina (Russia)

GLAUCOMA SURGICAL COMPLICATIONS

P26 Subconjunctival fragmentation of a previously efficient XEN gel stent implantation and successful bleb formation: a case report K. Novak - Lauš, L. Kneževic, G. Maric, M. Zoric Geber, Z. Vatavuk (Croatia)

P27 An unexpected complication after minimally invasive glaucoma surgery H.J.M. Beckers (Netherlands)


Montreal, Canada

35

POSTERS POSTERS

INTERNATIONAL OUTREACH

P28 The challenge of glaucoma surgery in isolated and remote settings: is MIGS the answer for outreach services? A. Agar, C. Ruan, J. Besley (Australia)

LASERS

P29 Micropulse versus continuous wave transscleral cyclophotocoagulation in refractory pediatric glaucoma Y. El Sayed, A. Abdelrahman (Egypt)

P30 Treatment outcomes of micropulse transscleral cyclophotocoagulation (MP-CPC) in Japanese refractory glaucoma K. Sugimoto, S. Asano, T. Fujishiro, R. Sakata, M. Honjo, M. Aihara (Japan)

P31 Transscleral diode cyclophotocoagulation in refractory glaucoma in eyes with good vision N. Palarie, T. Pasenco, I. Virlan (Moldova)

P32 Early results of subcyclo subthreshold diode laser transscleral cyclophotocoagulation S. Bayraktar, M. Karakaya, B. Karini, S. Albayrak, S. Pehlivanoglu, Z. Bayraktar, O.F. Yilmaz (Turkey)

P33 Clinical outcome of micropulse transcleral cyclophotocoagulation in glaucoma patients with no prior incisional glaucoma surgery P. Shah, O. Rai, V. Varikuti, B.-A. Lim, S.K. Dorairaj, S.F. Sieminski (USA)

P34 Diode laser cyclophotocoagulation in treatment of patients with refractory glaucoma A. Miljkovic, V. Canadanovic, N. Babic (Serbia)

P35 Pigment dispersion syndrome in a Filipino with Iris Bombe’: a case report K. Pormida (Philippines)



36

POSTERS POSTERS

NEW GLAUCOMA DRAINAGE DEVICES

P36 Glaucoma gel implant learning curve in a teaching tertiary hospital L. Abegão Pinto, R. Esteves Marques, N. Pinto Ferreira, D. Cordeiro Sousa, A. Barata, J. Medeiros Pinto, P. Sens (Portugal)

P37 A multi-centre interventional case series of 259 ab-interno Xen gel implants for glaucoma, with and without combined cataract surgery A. Karimi, A. Turnbull, C. Dimitriou, B. Bhatia, M. Radwan, P. Gouws, A. Hanifudin, N. Amerasinghe, A. Jacob, D. Lindfield (United Kingdom)

P38 Newfoundland ab interno gel stent study X. Campos-Möller (Canada)

P39 Unusual hypotony after Cypass microstent treated with diode laser - A case report E. Linton, L. Au (United Kingdom)

P40 Evaluation of second-generation trabecular micro-bypass stents in patients with glaucoma: a case series from the UK M. Parnell, P. Nderitu, M. Abu-Bakra, Y.-H. Tham, S. Trikha, G. Lascaratos, A. Kulkarni (United Kingdom)

P41 Material, design and mechanism of action of the InnFocus MicroShunt® Glaucoma Drainage System (MicroShunt) L. Pinchuk, O. Sadruddin (USA)

P42 A real world 12 month experience of 6 european centres with the XEN45 gel stent A. M. Fea1, A. Bron2, M. Economou3, G. Laffi1, E. Martini1, F. Oddone1

(1Italy, 2France, 3Sweden)

P43 1, 2, and 3 year results for standalone MIGS surgery in open angle glaucoma with the Hydrus® Microstent from the global SPECTRM Registry A. M. Fea, C. Lavia, L. Dallorto, T. Rolle (Italy)

P44 GATT: a Vancouver perspective L. Robinson, S. Schendel (Canada)

P45 IOP after phaco plus in phakic eyes and standalone iStent in pseudophakic eyes-preliminary results M. Nagar, A. Nagar, M. Pavel (United Kingdom)


Montreal, Canada

37

POSTERS POSTERS

P47 360° optical coherence tomography evaluation of the suprachoroid space after supraciliary microstent implantation A. De Gregorio, M. Montali, A. Bertoncello, G. Stevan, S. Morselli (Italy)

P48 12-month results of a multicentre open-label study of the InnFocus MicroShunt® glaucoma drainage system in patients with primary open-angle glaucoma (POAG) H. Beckers1, C. Webers1, F. Aptel2, E. Bluwol2, J. Martínez-de-la-Casa3, J. García-Feijoó3, Y. Lachkar2, C. Méndez-Hernández3, I. Riss2, T. Shaarawy4 (1Netherlands, 2France, 3Spain, 4Switzerland)

P49 To assess the hydrodynamic effect of a double Xen gel stent implant in glaucomatous eyes with a very compromised trabecular Meshwork permeability M. Montali, A. De Gregorio, G. Stevan, A. Bertoncello, S. Morselli (Italy)

P50 Standalone implantation of 1st generation trabecular micro-bypass stents

combined with topical prostaglandin in OAG patients on 2 medications: 5-year outcomes M. ElMallah (USA)

P51 Long-term follow up observational study of real life experience with trabecular first-generation micro-bypass stent implantation (iStent®) in patients with glaucoma L. Newball (Colombia)

P52 Xen surgery, approaches and findings C. Zheng, E.R. Craven (USA)

P53 Intermediate term outcomes of SIBS microshunt alone or in combination with phacoemulsification M.B. Schlenker, G.M. Durr, H. Gulamhusein, I.I.K. Ahmed (Canada)

P54 Standalone ab interno gelatin microstent implantation in glaucomatous eyes with narrow versus open angles: a retrospective cohort analysis G.M. Durr, H. Gulamhusein, D. Varma, D. Tam, I.I.K. Ahmed (Canada)

P55 Long-term outcomes of treatment with second-generation trabecular micro-bypass stents combined with topical prostaglandin in eyes with OAG on 2 preoperative medications A. Mermoud (Switzerland)



38

POSTERS POSTERS

NEW TECHNOLOGY

P56 Relationship between a sensing contact lens output and visual field glaucoma progression in open angle glaucoma: a practical tool to illustrate the likelihood of progression K. Hoskens, N. Midha, K. Mansouri (Switzerland)

P57 Intra-operative ASOCT: effect of phacoemulsification alone vs phaco-endocycloplasty on angle recess in Plateau Iris Syndrome - A preliminary report V. Puri, V. Pathak Ray (India)

P58 Six months retrospective analysis of iStent inject® implantation as a stand-alone procedure or in combination with cataract surgery for patients with open-angle glaucoma M.A. Economou, T.S. Arnljots (Sweden)

P59 A structural and functional machine learning classifier improves prediction of patient-reported disability in glaucoma S. Wakil, A.A. Jammal, N.G. Ogata, F.A. Medeiros (USA)

P60 Comparison between iStent inject® and Kahook dual-blade goniotomy. Early results T.S. Arnljots, M.A. Economou (Sweden)

NON-PENETRATING SURGERY

P61 Factors associated with successful intraocular pressure control by suture trabeculotmy with ab exerno and ab interno technique D. Shiba, S. Adachi, T. Ono, S. Hosoda, N. Ozeki, K. Yuki, M. Shimoyama, K. Tsubota (Japan)

P62 The place of surgical treatment in pigmentary glaucoma H. Boudedja, M. Dahmani, M. Azzouni, I. Aba Yahia, M. Terahi (Algeria)

P63 Gonioscopy-assisted transluminal trabeculotomy surgery: preoperative and postoperative factors affecting surgical outcomes Z. Aktas, C. Bektas, A.Y. Ucgul, S.S. Karamert (Turkey)


Montreal, Canada

39

POSTERS POSTERS

OCULAR IMAGING

P64 Low iris and anterior chamber volume associated with more anterior chamber deepening after laser peripheral iridotomy in primary angle closure suspects M. Pakravan, H. Esfandiari, S. Yazdani, N. Amouhashemi, K. Jadidi, P. Torkian, M. Yaseri (Iran)

P65 Optical coherence tomography angiography (OCTA) in glaucoma J. Novak (Czech Republic)

P66 Dual Scheimpflug imaging as a screening method for occludable angles - A comparison with gonioscopy N. Maes, B. Gomes, G. Rabelo, R. Souza (Brazil)

P67 Doppler imaging of internal carotid artery in asymmetrical primary open angle glaucoma S. Dangda, U. Yadava, M. Bhattacharyya (India)

TRABECULECTOMY

P68 Short-term results of minimally invasive trabeculectomy using adjunctive topical bevacizumab: a randomized clinical trial M. Arish, O. Bagherzadeh, S.S. Ahmadi (Iran)

P69 Effects of overhanging bleb after trabeculectomy on optical characteristics Y. Mizuno, R. Toda (Japan)

P70 Modified trabeculectomy to achieve inner flow procedure in glaucoma: a prospective study Y. Liang, H. Cheng, J. Meng, S. Zhang, Y. Xie (China)

P71 New way of surgical treatment of glaucoma O. Kiseleva, A. Bessmertny, A. Zhuravleva, E. Suleiman, K. Lugovkina (Russia)



40

POSTERS POSTERS

P72 Short-term efficacy and safety of ab interno trabeculectomy with Kahook dual blade in Japanese glaucoma patients T. Fujishiro, K. Sugimoto, R. Sakata, M. Honjo, M. Aihara (Japan)

P73 Outcomes of trabeculectomy with 5-fluorouracil versus ologen implant in primary open-angle glaucoma W. Shihadeh (Jordan)

P74 Hight frequency deep sclerotomy; Efficacy and safety M. M. Ebraheem, A. El-Shiaty, T. El-Beltagi, S. H. Salah (Egypt)

TUBE SHUNTS

P75 Ahmed glaucoma valve (AGV) tube insertion technique (graft sparing). Subhan’s scleral tunnel technique I.A. Subhan (Saudi Arabia)

P76 Efficacy and safety of Ex-Press® glaucoma filtration device in patients with normal tension glaucoma over 12 month after filtration surgery M. Aihara, Y. Kuwayama, K. Miyata, S. Otani, R. Ideta, Y. Hashimoto,

S. Shirato, N. Sasaki (Japan) P77 Ahmed glaucoma valve implantation; graft-free short tunnel small flap versus

scleral patch graft; a randomized clinical trial M. Pakravan1, M. Hatami1, H. Esfandiari2, S. Yazdani1, A. Doozande1, B. Kheiri1 (1Iran, 2USA)

P78 Clinical outcomes of anterior chamber versus ciliary sulcus placement of Baerveldt glaucoma implant M. Pastak, A. Kree (Estonia)

WOUND HEALING MODULATION

P79 Implantation of collagen matrix (Ologen®) versus mitomycin-C in Ex-Press device: a 3 years retrospective review I. Hernanz, C. Rodriguez-Bermejo, B. Sandoval (Spain)

P80 The effect of bevacizumab on the outcome of trabeculectomy with mitomycin C W. Suh (Korea)


Montreal, Canada

41

POSTERS POSTERS

P81 Triple modulation in glaucoma filtration surgery: our experience L. Tejwani, R. Sharma (India)

P82 Utility of collagen matrix implant as adjuvant in advanced cases of JOAG - Wound modulation R. Sharma, L. Tejwani (India)

P83 Anti-scarring effects of butaprost on human subconjunctival Tenon’s fibroblasts C.K. Lee (Korea)

OTHER

P84 Neovascular glaucoma and anti-VEGF : an overview and meta-analysis N.Y. Lee (Korea)

P85 Glaucoma screening: pros and cons T. Jesic Petrovic (Bosnia and Herzegovina)

P86 Use of a novel gait device to determine gait and postural stability in patients with advanced glaucoma C. Tan, D. Tan, K. Lun, C.S. Teoh (Singapore)

P87 44 ABIC patients: our experience with a mean of 50 weeks follow up

S. Kerkour, A. Aref, Y. Louati, T. Shaarawy, J.-M. Baumgartner (Switzerland)



42

WET LABSATURDAY, SEPTEMBER 8, 2018

08.30 MicroInvasive Glaucoma Surgery (MIGS) Wetlab Room10.30 Skills Transfer Course Course Directors: Toby Chan (Canada), Nir Shoham-Hazon (Canada)

Not CME accredited.


Montreal, Canada

43

13.00 EDUCATIONAL PARTNER LUNCH SYMPOSIUM Main Room14.30 ALCON SURGICAL Chair: Paul Harasymowycz (Canada)

13.30 Leon Au (United Kingdom)EP1.1

13.40 Leon Au (United Kingdom)EP1.2

13.50 Paul Harasymowycz (Canada)EP1.3

14.10 Steven D. Vold (USA) EP1.4

Not CME accredited.

FRIDAY, SEPTEMBER 7, 2018

08.00 EDUCATIONAL PARTNER BREAKFAST SYMPOSIUM Main Room09.00 ELLEX / DIOPSYS MANAGING THE GLAUCOMA PATIENT: EARLY DETECTION TO

EARLY INTERVENTION Chair: David Lubeck (USA)

08.00 PERG for better management of patients with glaucoma & SLTEP2.1 Mark A. Latina (USA)

08.30 Ab-interno canaloplasty (ABiC) in the MIGS treatment armamentarium EP2.2 Mahmoud Khaimi (USA)

Not CME accredited.

EDUCATIONAL PARTNER SYMPOSIATHURSDAY, SEPTEMBER 6, 2018



44

13.00 EDUCATIONAL PARTNER LUNCH SYMPOSIUM Main Room14.30 SANTEN SURGICAL OPTIONS FOR GLAUCOMA: HOW DO WE DECIDE? Chair: Matthew B. Schlenker (Canada)

13.30 Welcome and IntroductionEP3.1 Matthew B. Schlenker (Canada)

13.35 The role of surgery in glaucoma managementEP3.2 Matthew B. Schlenker (Canada)

13.50 Surgical options for mild-to-moderate glaucoma: a series of interactive case studiesEP3.3 Hady Saheb (Canada)

14.05 Surgical options for severe glaucoma:a series of interactive case studiesEP3.4 Henny Beckers (Netherlands)

14.20 Hybrid blebs: comfort and durabilityEP3.5 Tarek Shaarawy (Switzerland)

Not CME accredited.

SATURDAY, SEPTEMBER 8, 2018

12.30 EDUCATIONAL PARTNER LUNCH SYMPOSIUM Main Room14.00 ALLERGAN XEN KNOW-HOW: LEARNING BY SUCCESS EXPERT SESSION Chairs: Keith Barton (United Kingdom), Michael Coote (Australia),

Ingeborg Stalmans (Belgium)

13.00 Introduction by Chairs

13.02 Finding the place of XENEP4.1 Ingeborg Stalmans (Belgium)

13.12 Pre-operative optimisations EP4.2 Gokulan Ratnarajan (United Kingdom)

13.27 Intra-operative optimisationsEP4.3 Iqbal Ike Ahmed (Canada)

13.42 Post-operative optimisations EP4.4 Chelvin Sng (Singapore)

13.57 Discussion

Not CME accredited.

EDUCATIONAL PARTNER SYMPOSIAFRIDAY, SEPTEMBER 7, 2018


Montreal, Canada

45

EDUCATIONAL PARTNER SYMPOSIAFRIDAY, SEPTEMBER 7, 2018

Aba Yahia I., P62Abdelrahman A., P29Abdullatif A., FP4.4, V10Abdussalam A., MS3.3Abegão Pinto L., P36Abizgildina G., P19, P24Abu-Bakra M., P40Abubakra M., V11Adachi S., P61Agar A., FP6.2, MS1.6, P28Ahmadi S.S., P68Ahmed I.I., EP4.3, L3, MS8, MS8.3Ahmed I.I.K., P11, P53, P54Aihara M., P30, P72, P76Aktas Z., FP4, P63, V01, V06, V07Al-Harbi A., FP5.40Al-Jadaan I., FP5.4Ahmad S., FP5.4Alaghband P., FP2.2Alali A., P16Albayrak S., P32Aleksandrov A., P15Ali A., FP5.5Aljaber A., FP5.4Alsuhaibani M., FP5.4Altamimi L., FP5.4Amerasinghe N., P37 Amouhashemi N., P64An J., FP4.8Anand N., FP2.2Aptel F., P48Arad T., FP3.4Aref A., FP4.2, P87Arish M., P68Arnljots T.S., P58, P60Asano S., P30Asma A., P02Au L., EP1.1, EP1.2, FP5, FP5.7, FP6.7, MS3.2, P39Avdeev R., P15Ayesha K., PL2Azzouni M., P62

Babic N., P34Badakare S., FP5.1Bagheri M., FP5.5Bagherzadeh O., P68Bakunina N., P15Barata A., P36Barton K., EP4, FP4, FP6.7, MS6, MS6.1Basia A., FP1.4Baumgartner J.-M., P87Bayoumi N., FP2, P13Bayraktar S., P32Bayraktar Z., P32Beckers H-J.M., P27Beckers H., EP3.4, P48Behera A., V03, V08Bektas C., P63Belaya D., P15Berlin M., P12Bertoncello A., P47, P49Besley J., P28

Bessmertny A., P71Bezzabotnov A., FP3.2, FP3.3, FP3.7Bhatia B., P37Bhattacharyya M., P67Bilal M., V13Birt C., FP3, KL1, MS3.2, MS4Bluwol E., P48Boudedja H., P62Brezhnev A., P15Bron A., P42

Campos-Möller X., P38Canadanovic V., P34 Cantu M., FP6.7Carrière M., FP2.1Chakravarti T., P17, P22Chalifoux E., FP2.1 Chan H., FP1.3Chan T., MS9.2, WLChao-Po D.P., P01Chelvin S., PL2Cheng H., P70Cheng J.-C., P04Chiang M.-H., P04Choudhari N., FP5.1Chung J.K., P06Clement C., FP1, FP4.6, FP6.2, FP6.4, MS9.2Clements C., FP1.5Cook S., MS1.7 Coote M., EP4, L3, MS3.3, MS7, MS7.4, PC1Cordeiro Sousa D., P36Corridan P., FP5.10Craven E.R., P52Crichton A., FP6.8, MS9.3Crichton P., FP6.8

Dada T., IL3, FP1, FP2, M5, PL3, V03, V08Dahmani M., P62Dalianis G., FP2.3Dallorto L., FP6.1, P43Damji K., MS1.5, MS9.3Dangda S., P67De Gregorio A., P47, P49Desai A., V03Detorakis E., FP4.1Dimitriou C., P37Doozande A., P77Dorairaj S.K., FP4.5, FP5.6, P33 Dorey M., MS9.3Dorofeev D., P15Durr G.M., P53, P54Dushina G., FP3.2, FP3.3, FP3.7Dyukareva Y., P15

Economou M., P42, P58, P60El-Beltagi T., P74Ebraheem M.M., P74El Saied H., FP4.4, V10El Sayed Y., FP5, P29El-Shiaty A., P74ElMallah M.K., FP5.6, P50

Elsayed E., P13Esfandiari H., P64, P77Esteves Marques R., P36Ezzouhairi S.M., FP4.7, FP5

Falvey H., FP6.7Farajzadeh M., P12Fea A.M., FP6, FP6.1, P42, P43Fechtner R.D., FP3, MS4, PL2Frolov M., FP3.2, FP3.3, FP3.7Fujishiro T., P30, P72

Gabdrakhmanov L., P15Gabdrakhmanova A., P19Gagne S., FP2, FP5, FP6.6, MS3.1Gagrani M., V08Galimova A., P15Gar’kavenko V., P15García-Feijoó J., P48Getmanova A., P15Giers U., P12Gomes B., P66Gorodetskaya Y., FP3.5Gorodnichiy V., P15Gorodnichy V., P14Gouws P., P37Grehn F., FP3.4, FP6, MS3.2Groth S., FP1.6, MS7.1, MS9.1Guidotti J., FP5.9Gulamhusein H., P53, P54Gulati I., V12Gusarevich A., P15

Ha J.Y., P21Hafez A., MS8, MS8.2, PL3Hanifudin A., P37Harasymowycz P., EP1, EP1.3, FP5.2, MS3.1, MS4, MS7, MS7.2Hashimoto Y., P76Hatami M., P77 Hayrapetyan H., P20Hernanz I., P79Herndon L., MS1.2, MS2, MS6.3Hoffmann E., FP3.4Hollick E., V11Holmes D., FP4.6Honjo M., P30, P72Hopes M., FP5.8Hoskens K., P56Hosoda S., P61Howes F., FP6.4Hui M., FP1.5, FP4.6Hutnik C., FP2, IL2

Ideta R., P76Ikeda Y., FP3.1Imai K., FP3.1Ishikawa T., FP2.4

Jacob A., P37Jadidi K., P64Jammal A.A., P59 Jesic Petrovic T., P85Jolly J., FP1.3

Jones N., FP5.7Jones S., V11Jones T., FP6.7

Kahook M.Y., FP5.6Kane I., V04Kansal V., P11Karakaya M., P32Karamert S.S., P63Karimi A., FP3.6, FP5.8, P37, V02Karimov U., P15Karini B., P32Kasner O., P16Katz L.J., P23Kerkour S., P87Kerr N., FP6, MS3.1, MS9.1, PL3Khaimi M., EP2.2, FP5.3Kheiri B., P77Khohlova A., P15Khouri A., FP6.5 MS9.3Khoueir Z., MS9.3King C., FP1.1King J., FP4.8Kinoshita S., FP3.1Kiseleva O., P71Kiuchi Y., MS3.3Kleineberg L., P12Kneževic L., P26Kniestedt C., FP4.1Koh V., P09Kondrakova I., P15Kovalenko Y., FP3.5Kree A., P78Krinitsyna E., P14Kulkarni A., P40, V11Kumar V., FP3.2, FP3.3, FP3.7Kurbanov S., P19Kuroyedov A., P14, P15Kuwayama Y., P76

Lachkar Y., P48Laffi G., P42Lajoie C., FP2.1 Lanin S., P15Lascaratos G., P40, V11 Latina M.A., EP2.1Lavia C., FP6.1, P43Lebedev O., P20Lee C.K., P83Lee D., FP4.8Lee K.B., P06Lee N.Y., P84Lee S., FP5.10Lesk M., FP1, MS9.3, PC1Liang Y., P740Liebmann J.M., L2, MS2Lim B.-A., P33Lim K.S., MS1.4Lim R., FP6.2Lim Y., P09Lindfield D., FP3.6, FP5.8, P37, V02Linton E., P39Louati Y., P87Lovpache D., P15

CHAIR AND AUTHOR INDEX



46

Lubeck D., EP2, FP6.3Lugovkina K., P71Lun K., P86

Macapagal M.R., P01Macasaet A.M., P01Maes N., P66Magaramov D., P03Malhotra V., V12Malik R., FP5.4Manning D., FP6.4Mansouri K., FP4.5, FP5.9, MS3.3, P56Marcelo N., PL2Maric G., P26Martin K., FP5.8Martínez López-Corell P., V04Martínez Rubio C., V04 Martínez-de-la-Casa J., P48Martini E., P42Masoudnaseri M., FP4.3McHugh D., V11McHugh J., V11Medeiros F.A., P59Medeiros Pinto J., P36Meier-Gibbons F., MS7.3Méndez-Hernández C., P48Meng J., P70Mermoud A., FP4.1, FP4.2, FP5.9, M5, MS1, MS1.1, P55Midha N., P56Miljkovic A., P34Miller G., FP4, MS9.1Mireskandari K., FP5.5Miyake T., FP2.4Miyata K., P76Mizuno Y., P69Mofti A., FP5.4, M5, MS4Mohite A., FP5.10Molchanova E., P15Molina Pallete R., V04Montali M., P47, P49Mori K., FP3.1Morselli S., P47, P49Murthy S., FP5.10

Nagar A., P45Nagar M., P45Nagornova Z., P15Najm-Tehrani N., FP5.5Narita A., FP2.4Neelakantan A., MS3.1Nderitu P., P40Neo E., P09Newball L., P51Nouri M.T., P02Novak - Lauš K., P26Novak J., P65

Ocakoglu O., V06Oddone F., P42

Ogata N.G., P59Oliver K., MS6, MS6.2Ono T., P61Onufriychuk O., P15Otani S., P76Ozeki N., P61

Pakravan M., MS3.3, P64, P77Palarie N., P31Park S.W., P21Parnell M., P40, V11Pasenco T., P31Pastak M., P78Pathak Ray V., FP5.1, MS9.1, P08, P57, V12Patodia Y., P11Pavel M., P45Pehlivanoglu S., P32 Perera S., MS3.3, PC1 Petrov S., P15Pinchuk L., P41Pinto Ferreira N., P36Placinta I.A., V04Pormida K., P35Puri V., FP5.1, P08, P57

Qureshi A., FP5.7

Rabelo G., P66Radwan M., P37Rai O., P33Ramanathan S., FP5.10Rao D., FP5.1, P08, V12Ratnarajan G., EP4.2, FP1.1, FP1.3, FP6, MS3.1Realini A., MS1.3Reetika S., MS9.1Riss I., P48Robinson L., P44Rodriguez-Bermejo C., P79Roka V., P12Rolle T., P43Roy S., FP4.1, FP4.2Rozhko Y., P15Ruan C., P28

Sadruddin O., P41Saheb H., EP3.3, FP6, MS4, MS6.4Sakata R., P30, P72Salah S.H., P74Salimi A., FP5.2 Salinas L., FP4.5Salmon J., FP1.1, FP1.3Sanders E., FP6.8Sandoval B., P79Sangilbayeva Z., P15Sasaki N., P76Schendel S., MS3.1, P44Schlenker M.B., EP3, EP3.1, EP3.2, P53Seguchi J., FP2.4

Seibold L., FP4.5Seibold L.K., FP5.6Seif R., M5, MS4Seleznev A., P15Seng Chee L., MS3.2Sens P., P36Seong M., P07Sergeeva V., P14Sevciuc R., P15Shaarawy T., EP3.5, FP1, FP4.2, L1, MS2, MS4, P48, P87, PC1Shah P., P33Shahalova A., P15Shakrawal J., V03, V08 Sharma R., P10, P81, P82, V09Sherwin J., FP1.1Sherwood M., L2, MS4, MS5, MS9.2, PC1Sheybani A., P05, V05Shiba D., P61Shihadeh W., MS7, P73, V13Shimoyama M., P61Shirato S., P76Shiroma L., MS9.2Shiu M., FP6.4Shoham-Hazon N., WLShradqa A., FP3.2, FP3.3, FP3.7Sidhu T., V03, V08Sieminski S.F., P33Singh I.P. FP5.6Slagle G., FP1.6Sng C., EP4.4, MS3.2Sokolovskaya T., FP3.45, P03Sotozono C., FP3.1Southern UK Xen Audit Group, FP3.6Souza R., P66Sponsel W., FP1.6Sponsel W.E., L1, MS1Stalmans I., EP4, EP4.1, FP5, MS8, MS8.1Stergiopulos C., FP4.1Stergiopulos N., FP4.1Stevan G., P47, P49Stodtmeister R., P12Stolyarov G., P20Subhan I.A., P75Sugihara K., FP2.4Sugimoto K., P30, P72Suh W., P80Suleiman E., P71Sung M.S., P21Superstein R., P16

Tam D., P54Tam D.Y., P11Tan C., P86Tan D., P86Tashtitova L., P15Tejwani L., P10, P81, P82, V09Teoh C.S., P70Teplovodskaya V., P03

Terahi M., P62Terzidou C., FP2.3Tham Y.-H., P40, V11Thomsen S., FP4.8Toda R., P69Toeteberg M., P12Tong W.H., P09Topouzis F., FP4.1Torkian P., P64Trikha S., P40Trivli A., FP2.3Trope G.E., KL1Tsubota K., P61Turnbull A., P37

Ucgul A.Y., P63Ueno M., FP3.1Usmanov S., P15Uzunel U.D., P18

Varikuti V., P33Varma D., P54Varma D.K., P11Vatavuk Z., P26Vila Arteaga J., V04Villamarin A., FP4.1Virlan I., P31Vold S.D., EP1.4Volkova N., P15

Wakil S., MS2, P59Walkden A., MS3.2Wang J., MS9.1Webers C., P48White A., FP6.2Williamson B.K., FP5.6Wu C.-L., P04

Xie Y., P70

Yadava U., P67Yamamoto Y., FP3.1Yaseri M., P64Yashina V., P03Yazdani S., P64, P77Yilmaz O.F., P32Yohannan J., P11Yuki K., P61Yusuf I., FP1.3

Zakhidov A., P15Zavadskiy P., P15Zhang S., P70Zheng C., P52Zhuravleva A., P71Zoric Geber M., P26Zvereva O., P15

CHAIR AND AUTHOR INDEX

LegendaEP = Educational Partner Symposium; FP = Free Paper; KL = Keynote Lecture; L = Lecture; MS = Main Session; P = Poster; PC = Parallel Course; V = Video Loop; WT = Wetlab

Alcon is constantly striving to enhance quality of life by helping people see better.

We continue to set new standards in eye care through our commitment to developing new and innovative products and technologies to address unmet eye care needs of patients around the world.

Patients are at the center of everthing we do and at the heart of our commitment to helping people see better.

Alcon s’efforce constamment d’améliorer la qualité de vie en aidant les gens à mieux voir.

Chez Alcon, nous ne cessons d’établir de nouvelles normes en matière de soins oculaires en mettant au point des nouveaux produits et technologies novateurs, afin de répondre aux besoins non satisfaits dans le domaine des soins oculaires des patients partout dans le monde.

Les patients sont au centre de tout ce que nous faisons et au coeur de notre détermination à aider les gens à mieux voir.

Journal for Translational and Clinical Research

ESASO

Co

urse Series

Karg

erTraverso

/Stalman

s/To

po

uzis/B

agn

asco (ed

s.)G

lauco

ma

ESASO Course Series

F. Bandello, B. Corcóstegui

Vol. 8

Glaucoma Editors

C.E. TraversoI. StalmansF. TopouzisL. Bagnasco

8

Editor

Anat LoewensteinTel Aviv

www.karger.com/oph

Developments in Ophthalmology

Editor: F. Bandello

Vol. 59

GlaucomaSurgery2nd, revised and extended edition

Editors

P. BettinP.T. Khaw

Topical Karger Titles

Editor

José Cunha-VazCoimbra

www.karger.com/ore

ESASO Course Series, Vol. 8

GlaucomaEditors: Traverso, C.E. (Genoa); Stalmans, I. (Leuven); Topouzis, F. (Thessaloniki); Bagnasco, L. (Genoa)VIII + 130 p., 64 fig., 46 in color, 17 tab., 2016CHF 98.00 / EUR 92.00 / USD 115.00 ISBN 978–3–318–05890–1 (soft cover)www.karger.com/ecs

Developments in Ophthalmology, Vol. 59

Glaucoma Surgery2nd, revised and extended editionEditors: Bettin, P. (Milan); Khaw, P.T. (London)XII + 196 p., 79 fig., 69 in color, 11 tab., 2017CHF 198.00 / EUR 185.00 / USD 233.00ISBN 978–3–318–06039–3 (hard cover)www.karger.com/dop

KI18

265

online only

Medical and Scientific Publishers

I S G SApply for membership at

w w w . i s g s . i n f o

Date post:	25-Feb-2019
Category:	Documents
Upload:	buicong
View:	213 times
Download:	0 times

ICGS 2018 September 6-8, 2018 · Ph. +39 055 50351 • [email protected] ... General...

Documents